盐酸替罗非班氯化钠注射液联合心血管介入治疗急性心肌梗死的效果研究
[摘要]目的 探讨盐酸替罗非班氯化钠注射液联合心血管介入治疗急性心肌梗死的效果。方法 选取2015年6月～2017年12月我院接受治疗的60例急性心肌梗死患者为研究对象，将其随机分为两组，每组30例。对照组采用心血管介入治疗，观察组在对照组基础上增加盐酸替罗非班氯化钠注射液治疗。比较两组的临床效果及短期预后指标。结果 观察组的TIMI血流分级情况优于对照组，差异有统计学意义（P<0.05）。治疗前，两组患者的各项血小板活化功能指标比较，差异无统计学意义（P>0.05），治疗后，观察组患者的CD62P、CD63以及MPA阳性表达率明显优于治疗前和对照组，差异有统计学意义（P<0.05）。观察组患者的再发急性心肌梗死、猝死、恶性心律失常、严重出血事件发生率均明显低于对照组，差异有统计学意义（P<0.05）。结论 盐酸替罗非班氯化钠注射液联合心血管介入治疗急性心肌梗死的临床效果较显著，可降低不良预后的发生率，治疗安全性高，值得推广应用。
[关键词]盐酸替罗非班氯化钠注射液；心血管介入治疗；急性心肌梗死
[中图分类号] R542.2+2 [文献标识码] A [文章编号] 1674-4721（2018）7（a）-0063-03
[Abstract]Objective To investigate the effect of Tirofiban Hydrochloride Sodium Chloride Injection combined with cardiovascular intervention treating acute myocardial infarction.Methods Sixty patients with acute myocardial infarction treated in our hospital from June 2015 to December 2017 were selected as study objects and they were randomly divided into the two groups，and there were 30 patients in each group.The control group was treated with cardiovascular intervention.The observation group was treated with Tirofiban Hydrochloride Sodium Chloride Injection on the basis of the control group.The clinical effect and short-term prognosis indexes between the two groups were compared.Results TIMI blood flow grading in the observation group was better than that of the control group，and the difference was statistically significant （P<0.05）.There was no significant difference between the two groups in the...
|
== 试读已结束，如需继续阅读敬请充值会员 ==
|
|
本站文章均为原创投稿，仅供下载参考，付费用户可查看完整且有格式内容！
(费用标准：38元/2月，98元/2年，微信支付秒开通！) |
| 升级为会员即可查阅全文 。如需要查阅全文，请 免费注册 或 登录会员 |
|
